(Q43734668)

English

Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Kondo Y

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Toda Y

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kitajima H

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Oda H

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Nagate T

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kameo K

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Murakami S

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

809-815

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

A simple fluorometric assay for lipoperoxide in blood plasma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Antioxidants and atherosclerotic heart disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03527.X

21 January 2018

Identifiers

10.1046/J.1440-1681.2001.03527.X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43734668&oldid=2102918779"